You are here

  • Home
  • Archive
  • Volume 72, Issue 4
  • Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan

Article info

Article menu
Download PDFPDF
Letters
Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan

Authors

  1. Correspondence to Professor Shumpei Yokota, Department of Paediatrics, Yokohama City University School of Medicine, 3–9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236–0004, Japan; syokota{at}med.yokohama-cu.ac.jp
View Full Text

Citation

Yokota S, Imagawa T, Mori M, et al
Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
Annals of the Rheumatic Diseases 2013;72:627-628.

Publication history

  • Accepted October 28, 2012
  • First published November 30, 2012.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions